Analytical Strategy to Prioritize Alzheimer’s Disease Candidate Genes in Gene Regulatory Networks Using Public Expression Data

Alzheimer’s disease (AD) progressively destroys cognitive abilities in the aging population with tremendous effects on memory. Despite recent progress in understanding the underlying mechanisms, high drug attrition rates have put a question mark behind our knowledge about its etiology. Re-evaluation of past studies could help us to elucidate molecular-level details of this disease. Several methods to infer such networks exist, but most of them do not elaborate on context specificity and completeness of the generated networks, missing out on lesser-known candidates. In this study, we present a novel strategy that corroborates common mechanistic patterns across large scale AD gene expression studies and further prioritizes potential biomarker candidates. To infer gene regulatory networks (GRNs), we applied an optimized version of the BC3Net algorithm, named BC3Net10, capable of deriving robust and coherent patterns. In principle, this approach initially leverages the power of literature knowledge to extract AD specific genes for generating viable networks. Our findings suggest that AD GRNs show significant enrichment for key signaling mechanisms involved in neurotransmission. Among the prioritized genes, well-known AD genes were prominent in synaptic transmission, implicated in cognitive deficits. Moreover, less intensive studied AD candidates (STX2, HLA-F, HLA-C, RAB11FIP4, ARAP3, AP2A2, ATP2B4, ITPR2, and ATP2A3) are also involved in neurotransmission, providing new insights into the underlying mechanism. To our knowledge, this is the first study to generate knowledge-instructed GRNs that demonstrates an effective way of combining literature-based knowledge and data-driven analysis to identify lesser known candidates embedded in stable and robust functional patterns across disparate datasets.

[1]  Daniel Rios,et al.  Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor , 2022 .

[2]  R. Veerhuis,et al.  Establishment of microglial cell cultures derived from postmortem human adult brain tissue: Immunophenotypical and functional characterization , 2001, Microscopy research and technique.

[3]  G. Tseng,et al.  Comprehensive literature review and statistical considerations for microarray meta-analysis , 2012, Nucleic acids research.

[4]  Dan Xie,et al.  Dynamic trans-Acting Factor Colocalization in Human Cells , 2013, Cell.

[5]  G. Gibson.  GTEx detects genetic effects , 2015, Science.

[6]  Charles DeLisi,et al.  Pathway-based classification of cancer subtypes , 2012, Biology Direct.

[7]  Martin Hofmann-Apitius,et al.  Linking hypothetical knowledge patterns to disease molecular signatures for biomarker discovery in Alzheimer’s disease , 2014, Genome Medicine.

[8]  V. Vingtdeux,et al.  Calcium signaling in neurodegeneration , 2009, Molecular Neurodegeneration.

[9]  Nick C Fox,et al.  11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study , 2010, The Lancet Neurology.

[10]  俊成 木村（磯野）,et al.  Amyloid-β25-35 induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2 , 2014 .

[11]  Gang Lei,et al.  Fyn, a potential target for Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[12]  David T. Jones,et al.  Cascading network failure across the Alzheimer’s disease spectrum , 2015, Brain : a journal of neurology.

[13]  A. Grierson,et al.  Role of axonal transport in neurodegenerative diseases. , 2008, Annual review of neuroscience.

[14]  A. Hill,et al.  Intracellular Itinerary of Internalised β‐Secretase, BACE1, and Its Potential Impact on β‐Amyloid Peptide Biogenesis , 2013, Traffic.

[15]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[16]  Esa Kuismanen,et al.  Localization of plasma membrane t-SNAREs syntaxin 2 and 3 in intracellular compartments , 2005, BMC Cell Biology.

[17]  Jin Chen,et al.  Differential co-expression and regulation analyses reveal different mechanisms underlying major depressive disorder and subsyndromal symptomatic depression , 2015, BMC Bioinformatics.

[18]  Tudor A. Fulga,et al.  Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo , 2007, Nature Cell Biology.

[19]  Andreas Draguhn,et al.  Synthetic Aβ oligomers (Aβ(1-42) globulomer) modulate presynaptic calcium currents: prevention of Aβ-induced synaptic deficits by calcium channel blockers. , 2013, European journal of pharmacology.

[20]  Audrey Kauffmann,et al.  Bioinformatics Applications Note Arrayqualitymetrics—a Bioconductor Package for Quality Assessment of Microarray Data , 2022 .

[21]  J. Collins,et al.  Large-Scale Mapping and Validation of Escherichia coli Transcriptional Regulation from a Compendium of Expression Profiles , 2007, PLoS biology.

[22]  J. Cummings,et al.  Alzheimer’s disease drug-development pipeline: few candidates, frequent failures , 2014, Alzheimer's Research & Therapy.

[23]  P. Brown,et al.  Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Ralf Herwig,et al.  ConsensusPathDB: toward a more complete picture of cell biology , 2010, Nucleic Acids Res..

[25]  Enrico Glaab,et al.  Using prior knowledge from cellular pathways and molecular networks for diagnostic specimen classification , 2015, Briefings Bioinform..

[26]  John Quackenbush,et al.  Inference and validation of predictive gene networks from biomedical literature and gene expression data. , 2014, Genomics.

[27]  Antonella Plaia,et al.  Association between the interleukin-1β polymorphisms and Alzheimer's disease: A systematic review and meta-analysis , 2008, Brain Research Reviews.

[28]  Frank Emmert-Streib,et al.  Urothelial cancer gene regulatory networks inferred from large-scale RNAseq, Bead and Oligo gene expression data , 2015, BMC Systems Biology.

[29]  Eurie L. Hong,et al.  Annotation of functional variation in personal genomes using RegulomeDB , 2012, Genome research.

[30]  John Quackenbush,et al.  Seeded Bayesian Networks: Constructing genetic networks from microarray data , 2008, BMC Systems Biology.

[31]  M. Pazin.  Using the ENCODE Resource for Functional Annotation of Genetic Variants. , 2015, Cold Spring Harbor protocols.

[32]  A. Brookes,et al.  GWAS Central: a comprehensive resource for the comparison and interrogation of genome-wide association studies , 2013, European Journal of Human Genetics.

[33]  H GRUNEBERG,et al.  Human genetics. , 1947, The Eugenics review.

[34]  Frank Emmert-Streib,et al.  Organizational structure and the periphery of the gene regulatory network in B-cell lymphoma , 2012, BMC Systems Biology.

[35]  Laura Bleiler,et al.  2014 Alzheimer's disease facts and figures , 2014, Alzheimer's & Dementia.

[36]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[37]  Dan Zhang,et al.  The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits , 2012, Neurobiology of Aging.

[38]  L. Tran,et al.  Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.

[39]  Ron Shamir,et al.  Dissection of Regulatory Networks that Are Altered in Disease via Differential Co-expression , 2013, PLoS Comput. Biol..

[40]  G. Tseng,et al.  Comprehensive literature review and statistical considerations for GWAS meta-analysis , 2012, Nucleic acids research.

[41]  Chris Wiggins,et al.  ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context , 2004, BMC Bioinformatics.

[42]  Claudio Russo,et al.  Neurodegeneration in Alzheimer Disease: Role of Amyloid Precursor Protein and Presenilin 1 Intracellular Signaling , 2012, Journal of toxicology.

[43]  C. Parsons,et al.  Alzheimer's disease, β‐amyloid, glutamate, NMDA receptors and memantine – searching for the connections , 2012, British journal of pharmacology.

[44]  Fumio Nakamura,et al.  Amyloid-β25–35 induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2 , 2013, Neuroscience Research.

[45]  D. Hanger,et al.  Quantitation of glycogen synthase kinase‐3 sensitive proteins in neuronal membrane rafts , 2009, Proteomics.

[46]  C. M. Davenport,et al.  MHC class I immune proteins are critical for hippocampus-dependent memory and gate NMDAR-dependent hippocampal long-term depression , 2013, Learning & memory.

[47]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[48]  Sach Mukherjee,et al.  Network inference using informative priors , 2008, Proceedings of the National Academy of Sciences.

[49]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[50]  Dmitry Pushkarev,et al.  Whole-genome haplotyping using long reads and statistical methods , 2014, Nature Biotechnology.

[51]  Pak Chung Sham,et al.  GWASdb: a database for human genetic variants identified by genome-wide association studies , 2011, Nucleic Acids Res..

[52]  Peggy Hall,et al.  The NHGRI GWAS Catalog, a curated resource of SNP-trait associations , 2013, Nucleic Acids Res..

[53]  Martin Hofmann-Apitius,et al.  NeuroTransDB: highly curated and structured transcriptomic metadata for neurodegenerative diseases , 2015, Database J. Biol. Databases Curation.

[54]  John P. A. Ioannidis,et al.  Meta-analysis for ranked discovery datasets: Theoretical framework and empirical demonstration for microarrays , 2008, Comput. Biol. Chem..

[55]  H. Fröhlich,et al.  Network Based Consensus Gene Signatures for Biomarker Discovery in Breast Cancer , 2011, PloS one.

[56]  Frank Emmert-Streib,et al.  Bagging Statistical Network Inference from Large-Scale Gene Expression Data , 2012, PloS one.

[57]  P. Koulen,et al.  Novel mechanism of increased Ca2+ release following oxidative stress in neuronal cells involves type 2 inositol-1,4,5-trisphosphate receptors , 2011, Neuroscience.

[58]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[59]  M. R. Sepúlveda,et al.  Impairment of the activity of the plasma membrane Ca²⁺-ATPase in Alzheimer's disease. , 2011, Biochemical Society transactions.

[60]  E. Birney,et al.  High-resolution genome-wide in vivo footprinting of diverse transcription factors in human cells. , 2011, Genome research.

[61]  Kevin Kontos,et al.  Information-Theoretic Inference of Large Transcriptional Regulatory Networks , 2007, EURASIP J. Bioinform. Syst. Biol..

[62]  Jeffrey A. Chao,et al.  An RNA biosensor for imaging the first round of translation from single cells to living animals , 2015, Science.

[63]  P. Mcgeer,et al.  The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy , 2013, Acta Neuropathologica.

[64]  Kim N. Green,et al.  Linking Calcium to Aβ and Alzheimer's Disease , 2008, Neuron.

[65]  Wei Liu,et al.  Generation and Characterization of Spiking and Nonspiking Oligodendroglial Progenitor Cells from Embryonic Stem Cells , 2013, Stem cells.

[66]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[67]  Ilya Bezprozvanny,et al.  Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease , 2008, Trends in Neurosciences.

[68]  C. Sabatti,et al.  The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins, and role in neurite outgrowth , 2009, Molecular Psychiatry.

[69]  Lisa Helbling Chadwick,et al.  The NIH Roadmap Epigenomics Program data resource. , 2012, Epigenomics.

[70]  Yuan Tian,et al.  Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy , 2013, Proceedings of the National Academy of Sciences.

[71]  Susumu Goto,et al.  KEGG for integration and interpretation of large-scale molecular data sets , 2011, Nucleic Acids Res..

[72]  Roberto Weigert,et al.  Multiple roles for the actin cytoskeleton during regulated exocytosis , 2012, Cellular and Molecular Life Sciences.

[73]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[74]  Jonathan E. Clark,et al.  Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer , 2013, BMC Systems Biology.

[75]  Bruno Vellas,et al.  Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions , 2015, The Lancet Neurology.

[76]  Brian J Bennett,et al.  Genetic network identifies novel pathways contributing to atherosclerosis susceptibility in the innominate artery , 2014, BMC Medical Genomics.

[77]  Trey Ideker,et al.  Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..

[78]  Michael Watson,et al.  CoXpress: differential co-expression in gene expression data , 2006, BMC Bioinformatics.

[79]  P. Geurts,et al.  Inferring Regulatory Networks from Expression Data Using Tree-Based Methods , 2010, PloS one.

[80]  M. R. Sepúlveda,et al.  Calmodulin antagonizes amyloid-β peptides-mediated inhibition of brain plasma membrane Ca(2+)-ATPase. , 2012, Biochimica et biophysica acta.

[81]  K. Mullane,et al.  Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond? , 2013, Biochemical pharmacology.

[82]  Undurti N. Das,et al.  Brain-derived neurotrophic factor and its clinical implications , 2015, Archives of medical science : AMS.

[83]  Bill C. White,et al.  Differential co-expression network centrality and machine learning feature selection for identifying susceptibility hubs in networks with scale-free structure , 2015, BioData Mining.

[84]  Martin Hofmann-Apitius,et al.  Mining biomarker information in biomedical literature , 2012, BMC Medical Informatics and Decision Making.

[85]  Juan M. Vaquerizas,et al.  DNA-Binding Specificities of Human Transcription Factors , 2013, Cell.

[86]  Xiang Li,et al.  Identification of active transcription factor and miRNA regulatory pathways in Alzheimer's disease , 2013, Bioinform..

[87]  Xinkun Wang,et al.  Functional Genomics of Brain Aging and Alzheimer’s Disease: Focus on Selective Neuronal Vulnerability , 2010, Current genomics.

[88]  Helen Parkinson,et al.  ArrayExpress: A Public Repository for Microarray Data , 2006 .

[89]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[90]  Manolis Kellis,et al.  HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..

[91]  Murali M. Yallapu,et al.  Curcumin nanoformulations: a future nanomedicine for cancer. , 2012, Drug discovery today.

[92]  Dapeng Liang,et al.  Concerted Perturbation Observed in a Hub Network in Alzheimer’s Disease , 2012, PloS one.

[93]  A.H.B. Bollen,et al.  BioConductor: Microarray versus Next-Generation Sequencing toolsets , 2014 .

[94]  Gerold Schmitt-Ulms,et al.  Overcoming barriers and thresholds – signaling of oligomeric Aβ through the prion protein to Fyn , 2013, Molecular Neurodegeneration.

[95]  Helga Thorvaldsdóttir,et al.  Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..

[96]  Erik L L Sonnhammer,et al.  Avoiding pitfalls in gene (co)expression meta-analysis. , 2014, Genomics.

[97]  Jianzhi Zhang,et al.  Why Do Hubs Tend to Be Essential in Protein Networks? , 2006, PLoS genetics.

[98]  David A Bennett,et al.  Higher brain BDNF gene expression is associated with slower cognitive decline in older adults , 2016, Neurology.

[99]  B T Hyman,et al.  Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. , 2000, The American journal of pathology.